M&A Deal Summary

SipNose Acquires SipNose - Device Technology Assets

On October 9, 2024, SipNose acquired medical products company SipNose - Device Technology Assets from Aptar Pharma

Acquisition Highlights
  • This is SipNose’s 1st transaction in the Medical Products sector.
  • This is SipNose’s 1st transaction in Israel.

M&A Deal Summary

Date 2024-10-09
Target SipNose - Device Technology Assets
Sector Medical Products
Buyer(s) SipNose
Sellers(s) Aptar Pharma
Deal Type Divestiture

Target

SipNose - Device Technology Assets

Yokneam, Israel
SipNose's Device Technology Assets includes a variety of devices technology assets that are designed and adapted to fit a wide range of therapies. SipNose's Device Technology Assets is based in Yokneam, Israel.

Search 200,577 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

SipNose


Category Company
DESCRIPTION


DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
Country (Israel) 1 of 1
Year (2024) 1 of 1

Seller(S) 1

SELLER

Aptar Pharma

Crystal Lake, Illinois, United States

Category Company
Sector Medical Products
DESCRIPTION

Aptar Pharma offers drug delivery systems, services and active material science solutions. Aptar Pharma is based in Crystal Lake, Illinois.


DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
Country (Israel) 1 of 1
Year (2024) 1 of 1